メインコンテンツに移動

Under fire

Broadsides aimed at the synthetic securitisation market, and by implication, the credit derivatives market by the chairman of the FSA have left bankers fuming. But while the asides from the UK regulator may have shown a lack of understanding of the big picture, the issues surrounding the rise of insurance investment banking should not be taken lightly. Mark Pelham reports.

heathcote-march02-gif
Synthetic securitisations, and by implication the credit derivatives market that underpins them, have recently come under scrutiny and in some cases heavy criticism from regulators, particularly over their use in transferring credit risk from the banking to the insurance sectors. Although there is some basis for concern, with insurance companies’ results suffering because of their synthetic

コンテンツを印刷またはコピーできるのは、有料の購読契約を結んでいるユーザー、または法人購読契約の一員であるユーザーのみです。

これらのオプションやその他の購読特典を利用するには、info@risk.net にお問い合わせいただくか、こちらの購読オプションをご覧ください: http://subscriptions.risk.net/subscribe

現在、このコンテンツをコピーすることはできません。詳しくはinfo@risk.netまでお問い合わせください。

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

ログイン
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here